Human Immunodeficiency Virus
Conditions
Interventions
be 
evaluated:
1. 
to 
Western blotting
HIV nucleic acid testing.
Index test:Reagent 
immunodeficiency 
and 
combined 
detection 
kit 
(chemiluminescence 
Sponsors
Beijing You'an Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Normal Group (those who meet the following two criteria): (1) The HIV antigen and antibody of the samples tested with the marketed reagent were negative. (2) Population without the interference type shown in table 1 in clinical protocol. 2.Interference Group (those who meet the following two criteria at the same time) : (1) The HIV antigen and antibody of the samples tested with the marketed reagent were negative. (2) The intervention population was included in combination with clinical diagnosis or test results. 3. Positive Group (HIV infection group): Patients clinically diagnosed as AIDS or HIV infection, or with HIV antibody confirmation test report.
Exclusion criteria
Exclusion criteria: 1. Turbid samples, samples with obvious microbial pollution; 2. The collection, processing and storage of samples do not meet the requirements of standard laboratory operation and product specification; 3. The sample size is not enough to complete the test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HIV;Consistency; | — |
Countries
China
Contacts
Public ContactChuanmin Tao
West China Hospital of Sichuan University
Outcome results
None listed